Table 1
National SARS-CoV-2 antibody seroprevalence estimates, by antibody seroprevalence type and sex
| Antibody seroprevalence overall percentage | Low 95% Confidence Interval | High 95% Confidence Interval | Antibody seroprevalence due to infection percentage | Low 95% Confidence Interval | High 95% Confidence Interval | Antibody seroprevalence due to vaccination percentage | Low 95% Confidence Interval | High 95% Confidence Interval | |
|---|---|---|---|---|---|---|---|---|---|
| Both Sexes | 3.6 | 2.6 | 4.2 | 2.6 | 1.6 | 3.2 | 1.0 | 0.0 | 1.3 |
| Males | 3.3 | 2.2 | 4.1 | 2.8 | 1.8 | 3.6 | 0.4 | 0.0 | 0.6 |
| Females | 3.9 | 2.8 | 4.7 | 2.4 | 1.3 | 3.0 | 1.5 | 0.5 | 2.0 |
Note(s):
Some seroprevalence estimates may not add correctly due to rounding.
Source(s):
Statistics Canada; Canadian COVID-19 Antibody and Health Survey (5339).
Report a problem on this page
Is something not working? Is there information outdated? Can't find what you're looking for?
Please contact us and let us know how we can help you.
- Date modified: